JPRN-UMIN000033089已完成3 期
Optimization of Extended-Release Tacrolimus Dose with Mycophenolate Mofetil based Immunosuppression in De novo Kidney Transplant Recipients using extensive pharmacokinetics monitoring - Optimization of Extended-Release Tacrolimus Dose with Mycophenolate Mofetil based Immunosuppression
Department of Transplant Surgery Kidney Disease Center Nagoya Daini Red Cross Hospital0 个研究点目标入组 60 人开始时间: 2018年6月30日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Multiple organ recipient or previous transplant history. 2) HLA identical living related donor. 3) ABO incompatible or T cell CDC-crossmatch positive case. 4) HIV, HCV, HBsAb positive recipients.
研究者
相似试验
招募中
不适用
Extended Release Tacrolimus on Intrapatient Variability in Kidney Transplant RecipientsIRCT20211221053480N1Shahid Beheshti University of Medical Sciences100
尚未招募
不适用
A clinical trial to adjust the dose of Tacrolimus in renal transplant patients with fast liver metabolismCTRI/2023/02/049758IQRAA INTERNATIONAL HOSPITAL AND RESEARCH CENTER
招募中
不适用
Clinical trial in assigning of tacrolimus dosage regimen according to CYP3A5 genotype in kidney transplant recipientsKidney transplatation patientsTCTR20131019001The National Science and Technology Development Agency140
进行中（未招募）
1 期
Dose optimization of tacrolimus using Bayesian prediction including pharmacogenetic variables in renal transplant patients.PROPHYLAXIS OF ALLOGRAFT REJECTION AFTER RENAL TRASPLANT.MedDRA version: 19.0Level: PTClassification code 10038533Term: Renal transplantSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2016-000340-34-ESHOSPITAL UNIVERSITARI DE BELLVITGE
尚未招募
不适用
Analysis of efficacy and safety of tacrolimus extended-release formulation on prevention of rejection and GVHD in allo-HSCT patientsallo hematopoietic stem cell transplantations of hematopoietic disordersJPRN-UMIN000008004Tokyo Women's Medical University15